Related Experiment Video
Updated: May 28, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Gastric infection by Helicobacter pylori
George Sachs1, David R Scott, Yi Wen
1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. gsachs@ucla.edu
Current Gastroenterology Reports
|October 14, 2011
Summary
Helicobacter pylori, a common infection causing ulcers and cancer, uniquely adapts to stomach acid. Rising antibiotic resistance necessitates new eradication strategies and drug targets.
Area of Science:
- Microbiology
- Gastroenterology
- Pathogenesis
Background:
- * Helicobacter pylori infects approximately 50% of the global population, contributing to gastric ulcers and cancer.
- * This bacterium, a neutralophile, survives in the stomach's acidic environment via acid acclimation, maintaining internal pH for viability.
- * Increasing antibiotic resistance has reduced H. pylori eradication rates below 80%, driving the search for alternative treatments.
Purpose of the Study:
- * To review the gastric biology of H. pylori, focusing on its acid acclimation mechanisms.
- * To discuss current detection methods and the challenge of antibiotic resistance.
- * To explore the influence of gastric acidity on antibiotic efficacy and propose novel therapeutic targets.
Main Methods:
- * Comprehensive literature review of H. pylori biology, acid acclimation, and antibiotic resistance.
- * Analysis of the role of gastric acidity in H. pylori susceptibility to antibiotics.
- * Identification and proposal of novel drug targets for H. pylori eradication.
Main Results:
- * Detailed explanation of H. pylori's acid acclimation process to survive in the gastric milieu.
- * Examination of the impact of rising antibiotic resistance on treatment effectiveness.
- * Identification of potential new drug targets to overcome resistance and enhance eradication.
Conclusions:
- * Understanding H. pylori's acid acclimation is crucial for developing effective treatments.
- * Novel drug targets are needed to combat antibiotic resistance and improve eradication rates.
- * Targeting gastric acidity's role in susceptibility may offer new therapeutic avenues.
Related Concept Videos
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.